Healthcare Gateway News

The latest news from Healthcare Gateway


May 2021

Breakthrough medical device to improve prediction of preterm birth

Aeterna Zentaris Announces the Selection of a Development Candidate in the DC-PTH Program for the Potential Treatment of Primary Hypoparathyroidism

April 2021

ScHARR researchers collaborate on a European research project to raise awareness of the impact of hypoglycaemia on people’s lives

March 2021

European Medicine Agency issues positive opinion for Diurnal’s second product in Europe

New study finds strong immune response following Covid-19 vaccination 

Sheffield scientists awarded £1.2 million to design Parkinson’s drug

New gene therapy innovation centre to advance scientific discoveries into life-changing treatments

February 2021

Treating neurodegenerative diseases by boosting mitochondria

PhD student conducts research on Ex-vivo high-throughput drug screening in bladder cancers

January 2021

New £1.6 million research project to support development of drug candidate for the treatment of motor neuron disease (MND)

Professor James Catto awarded £2.9 million in funding by Yorkshire Cancer Research for two major clinical trials

December 2020

Hidden damage to lungs from Covid-19 revealed in new study from University of Sheffield

November 2020

University of Sheffield and Pfizer lead new €25.5 million project to accelerate development of Advanced Therapy Medicinal Products

October 2020

New partnership to progress treatments for neuroinflammatory diseases

September 2020

Scientists discover new drug which could improve life expectancy and quality for pancreatic cancer patients

August 2020

Sheffield immunologists part of unprecedented national effort to search for answers on Covid-19

July 2020

Scientists collaborate to understand antibody responses in Covid-19

Encouraging early study for investigational drug in people with motor neurone disease

June 2019

New simple test could lead to early detection of cortisol deficiency

A world top-100 university

We're a world top-100 university renowned for the excellence, impact and distinctiveness of our research-led learning and teaching.